Veraxa Biotech receives PEI scientific advice on BiTAC-TCE development plan

Reuters2026/07/20 11:01

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Veraxa Biotech received Scientific Advice from Germany’s Paul-Ehrlich-Institute on the biology and non-clinical development plan for its lead BiTAC-TCE program.
Regulatory feedback supported the platform rationale, providing early de-risking and clearer guidance on safety assessments and pharmacokinetics strategy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veraxa Biotech AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607200700OMX_____CNEWS_EN_GNW1001213475_en) on July 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Veraxa Biotech receives PEI scientific advice on BiTAC-TCE development plan

You may also like

Crypto prices